PPAR-γ is highly expressed at inflammatory lesions in inflammatory arthritis, inflammatory bowel disease, and atherosclerotic plaques and has been considered a novel therapeutic target for those conditions [6]. This evidence concerns the gene PPARG and inflammatory bowel disease.